Accsys Technologies — Stronger than expected H123 results

Accsys Technologies (AIM: AXS)

Last close As at 27/03/2024

GBP0.59

3.40 (6.12%)

Market capitalisation

GBP134m

More on this equity

Research: Industrials

Accsys Technologies — Stronger than expected H123 results

Accsys reported stronger than expected H123 results, with significantly increased sales prices offsetting the higher raw material costs. The fourth reactor in Arnhem is ramping up quickly and Accsys expects H2 volumes to be c 50% higher than in H1. The construction of the Accoya plant in the United States is on schedule, but the Tricoya plant in Hull will take at least six months for Accsys to consider all options and validate the exact costs and funding needed for completion. We have raised our estimates and left our DCF assumptions unchanged, resulting in a value per share of €1.00.

Johan van den Hooven

Written by

Johan van den Hooven

Analyst

Industrials

Accsys Technologies

Stronger than expected H123 results

H123 results

General industries

8 December 2022

Price

68p/€0.79

Market cap

£150m/€173m

€1.16/£

Net debt (€m) at 30 September 2022

61

Shares in issue

218.8m

Free float

60%

Code

AXS

Primary exchange

LSE

Secondary exchange

Euronext Amsterdam

Share price performance

%

1m

3m

12m

Abs

9.4

(22.1)

(58.9)

Rel (local)

6.4

(24.1)

(58.8)

52-week high/low

181p

54p

Business description

Accsys Technologies is a chemical technology company focused on the development and commercialisation of a range of transformational technologies based on the acetylation of solid wood and wood elements for use as high-performance, environmentally sustainable construction materials.

Next events

FY23 results

June 2023

Analyst

Johan van den Hooven

+44 (0)20 3077 5700

Accsys Technologies is a research client of Edison Investment Research Limited

Accsys reported stronger than expected H123 results, with significantly increased sales prices offsetting the higher raw material costs. The fourth reactor in Arnhem is ramping up quickly and Accsys expects H2 volumes to be c 50% higher than in H1. The construction of the Accoya plant in the United States is on schedule, but the Tricoya plant in Hull will take at least six months for Accsys to consider all options and validate the exact costs and funding needed for completion. We have raised our estimates and left our DCF assumptions unchanged, resulting in a value per share of €1.00.

Year end

Revenue
(€m)

EBITDA*
(€m)

Net profit*
(€m)

EPS*
(€)

EV/sales
(x)

EV/EBITDA
(x)

03/21

99.8

10.1

1.3

0.01

3.7

36.8

03/22

120.9

10.4

2.1

0.01

3.3

38.2

03/23e

147.7

18.1

6.6

0.03

1.7

14.1

03/24e

178.9

26.3

12.0

0.05

1.4

9.6

Note: *EBITDA, net profit and EPS are normalised, excluding amortisation of acquired intangibles and exceptional items.

Higher sales prices drive good performance in H123

Revenues in H123 increased by 5% to €58.9m after a flat performance in the first five months of the year. The fourth reactor in Arnhem became operational in September and is ramping up. Underlying EBITDA remained stable despite challenging market conditions and production disruptions (related to the start-up of the fourth reactor). There was no further news on the stopping of construction of the plant in Hull, which was announced in early November, apart from the related non-cash impairment charge of €58m. Net debt increased by €34m to €61m, driven by investments in the United States, Arnhem and Hull and higher inventories, partly offset by the €19m capital raise (net of expenses) in May 2022.

Demand for Accoya and Tricoya remains strong

Accsys says demand for its products remains high and it provided positive guidance for H2 as it expects c 50% higher volumes than in H1. Reactors one to three in Arnhem are running at capacity, while the fourth is ramping up quickly (we estimate at 60% of its 20,000m³ capacity in H223). We have raised our estimates following the stronger H123 results and now expect 22% revenue growth in FY23 with a 370bp higher EBITDA margin of 12.3%. The construction of the US Accoya plant is on schedule to be completed in March 2024 (adding 43,000m³ capacity), while we still assume that the construction of the Tricoya plant in Hull will be continued and operational in March 2024 at the earliest (adding 40,000m³ in capacity).

Valuation: Higher value on higher pricing

Accsys is trading on FY23e multiples of 1.7x EV/sales and 14.1x EV/EBITDA. Our DCF model is based on four reactors in Arnhem and one in Hull, and we add a value for the Accoya US joint venture. On higher estimates we derive a value of €1.00 per share (previously €0.95).

Better than expected results in H123

Accsys published better than expected H123 results (to 30 September), after its trading update for the first five months on 12 September. After flat revenues to August, September was good with the first full-month contribution from the fourth reactor in Arnhem. Revenues in H1 increased 5% to €58.9m with higher-than-expected sales price increases compensating for the decline in Accoya volumes (-19% to 23,957m³ vs -24% in the first five months and in line with our estimated 24,000m³). The lower volumes were caused by continuing capacity constraints and the shutdown of the plant in Arnhem in April/May around the completion and commissioning of the fourth reactor. The average sales price for traditional Accoya was up 36% including the energy price premium since May 2022. The average price for wood sales to Medite and Finsa for the manufacture of Tricoya panels used to develop the market for Tricoya products was up 13%.

Exhibit 1: H123 results (ending 30 September 2022)

€m

H122

H123

Change y-o-y

Revenues

56.2

58.9

5%

Accoya wood volumes, m3

29,555

23,957

-19%

Gross margin

30.6%

30.8%

EBITDA normalised

4.5

4.5

0%

Net profit normalised

(0.9)

(0.9)

0%

Source: Accsys Technologies

Gross profit was up 5% with sales price increases offsetting the higher input costs. Group gross margin was up 20bp to 30.8% with the Accoya manufacturing margin only declining 20bp to 30.8%, which is a good result given the challenging market conditions and the production disruption in H1. Despite downwards volumes and upwards input costs pressures, underlying EBITDA was stable at €4.5m, driven by higher sales price. Exhibit 2 shows the development in EBITDA in H123, with a significant positive sales price impact of €11.1m, which can be broken down in €8.9m higher sales prices, a €0.7m energy price premium effect and a €1.5m positive currency effect. This price effect compensated for the volume decline (impact of €3.3m) and higher input prices (net acetyls price up 49% and raw wood price up 14%). Strict cost control limited the increase in other opex (excluding depreciation) to 5%.

Exhibit 2: Development of EBITDA in H123 versus H122

Source: Accsys Technologies

Net debt in H123 increased €34.2m to €61.4m (see Exhibit 3), mainly due to the €29m investment in the Accoya JV in the United States (construction remains on schedule) and capex of €23m for the fourth reactor in Arnhem and the first Tricoya plant in Hull. Also, inventories were €12m higher ahead of the ramp up of the fourth reactor and temporary build-up of work-in-progress and finished goods. In May 2022, Accsys raised new capital of €19m (net of expenses) to strengthen its balance sheet and fund the completion of the fourth reactor in Arnhem. For the second half, management is focused on cost and cash management and a reduction in inventories, which should lead to higher cash generation in the second half. Our new estimates assume a net debt level of around €53m at end FY23.

Exhibit 3: Development net debt in H123

Source: Accsys Technologies

Impairment of Tricoya assets

Following the restructuring of the Tricoya consortium in early November, which we commented on in our last update, Accsys has full ownership of Tricoya Technologies and Tricoya UK. The company has also put the construction of the Tricoya plant on hold for at least six months, during which period the remaining work and costs will be validated and Accsys will look into the required funding while considering all potential options for the plant. No further news was announced at the H1 results.

On 2 November, Accsys stated that it would record a material non-cash impairment of a proportion of the fixed assets related to Tricoya at the H123 results, which came in at €58m and included €3.8m in intangible fixed assets and €52.5m in tangible fixed assets. Accsys mentioned several reasons for this impairment: (1) higher capex of up to €35m for the completion of the Tricoya plant in Hull, (2) ongoing costs of €0.5m per month during the hold period, (3) a higher discount rate due to higher market interest rates, and (4) higher acetyls prices affecting future operational cash flows.

Exhibit 4 shows the impact that, according to the company, several factors could have on the valuation of the Tricoya assets (if made in isolation):

Exhibit 4: Changes to key assumptions for current impairment of €58m

Impact in €m

1% increase in the market interest rates (through increasing the discount rate, which currently is 12.8%)

10

1% decrease in the long-term growth rate (currently 2.5%)

7

1% decrease to gross margin (currently targeted at 40%)

4

Three-month extension in the hold period (currently assumed at nine months)

2

€5m increase in the capital costs to bring the plant into commercial operation

4

1% increase in the market interest rates (through increasing the discount rate, which currently is 12.8%)

1% decrease in the long-term growth rate (currently 2.5%)

1% decrease to gross margin (currently targeted at 40%)

Three-month extension in the hold period (currently assumed at nine months)

€5m increase in the capital costs to bring the plant into commercial operation

Impact in €m

10

7

4

2

4

Source: Accsys Technologies

According to management, Accsys wants to complete the plant and it will take at least six months to decide how to proceed. We still assume that construction will be continued, with the plant being operational in March 2024 at the earliest. This adds 40,000m³ in capacity with estimated revenues of €50m. Assuming internal cash flows of c €10m and potential higher debt of around €5m, this leaves an additional capital raise assumption of up to €20m in about six months, depending on the outcome of the company’s assessment of how much it will cost to complete the plant in Hull.

Higher estimates on higher sales prices

According to Accsys, demand for Accoya and Tricoya remains strong with a robust customer order book over the next three months and beyond. The company is very positive for H223 as it started off well in October with volumes of 6,600m³ (including some unwinding of work in progress, thus not indicative of a monthly run rate) and it expects volumes in the second half to be c 50% higher than in H1, or c 36,000m³. According to Accsys, reactors one to three in Arnhem are running at capacity, which we think should deliver around 30,000m³ in volumes in the second half, leaving 6,000m³ for the fourth reactor, or 60% of capacity. During the analyst call, management reiterated its aim for a ramp up period of two years for the fourth reactor, but given the current forecast for H2 we think this might be realised before year-end 2023, or in 16 months.

The construction of the US Accoya plant is on schedule, with ground works and deep drilling successfully completed followed by the commencement of steelwork. Accsys still expects the plant to be operational in March 2024, adding 43,000m³ in capacity with potential revenues of €95m.

We have raised our full year revenue and EBITDA estimates after the better-than-expected H123 results, which were mainly the result of higher-than-expected sales prices (for Accoya €2,420 per m³, +36%). These also have a positive impact on FY24, so we have raised our revenue estimate by 12% and EBITDA by 27%.

Exhibit 5: Change in P&L estimates

€m

FY23e

FY24e

FY25e

Old

New

Change

Old

New

Change

Old

New

Change

Sales

138.5

147.7

6.7%

159.8

178.9

11.9%

204.6

221.4

8.2%

Gross margin

29.7%

31.0%

29.6%

31.1%

31.8%

31.2%

EBITDA normalised

16.0

18.1

13.0%

20.7

26.3

27.0%

34.7

34.9

0.5%

EBITDA margin

11.6%

12.3%

12.9%

14.7%

17.0%

15.8%

Net profit (reported)

(26.6)

(19.7)

-25.9%

7.8

12.0

52.5%

19.8

19.0

-3.8%

Net profit (normalised)

4.9

6.6

34.6%

7.8

12.0

52.5%

19.8

19.0

-3.8%

Source: Edison Investment Research

Our updated estimates assume revenue growth of 21% in FY24 and 24% in FY25, driven by better pricing, the ramp up of the fourth reactor in Arnhem and the first contribution of the Hull plant in FY25. EBITDA margins are expected to increase steadily as Arnhem scales up. Tricoya potentially has a higher margin, but we now think that this will only become visible in FY26 as FY25 will be its first year of ramping up volumes, which means below average margins until then.

Valuation

To value Accsys we use a discounted cash flow (DCF) model as there are no other listed companies with a comparable business profile. Accsys is trading on FY23e multiples of 1.7x EV/sales and 14.1x EV/EBITDA. Our DCF model is based on four reactors in Arnhem and one in Hull and we add a separate value for the Accoya plant in the United States, which is expected to be operational in mid-2024 after construction started in April 2022. On our higher estimates and unchanged assumptions, our DCF indicates a value per share of €1.00 (previously €0.95).

Exhibit 6: Financial summary

€m

FY21

FY22

FY23e

FY24e

FY25e

Year end 31 March

IFRS

IFRS

IFRS

IFRS

IFRS

INCOME STATEMENT

Revenue (reported)

99.8

120.9

147.7

178.9

221.4

Gross Profit

33.1

36.0

45.7

55.7

69.1

EBITDA normalised

10.1

10.4

18.1

26.3

34.9

EBITDA reported

10.2

10.3

18.1

26.3

34.9

Depreciation & Amortisation

(5.7)

(6.2)

(7.8)

(8.6)

(8.9)

EBIT normalised

4.4

4.2

10.4

17.7

26.0

Exceptionals (Edison definition)

0.1

(0.1)

(58.5)

0.0

0.0

EBIT reported

4.5

4.1

(48.1)

17.7

26.0

Net Interest

(4.1)

(2.3)

(0.3)

(3.5)

(4.0)

Results of associates

(0.1)

0.0

(0.8)

(0.8)

(0.8)

Profit Before Tax

0.3

1.8

(48.4)

14.2

22.0

Reported tax

(1.3)

(1.0)

(0.6)

(1.4)

(2.2)

Profit After Tax

(0.9)

0.7

(49.0)

12.8

19.8

Minority interests

1.4

1.6

30.2

0.0

0.0

Net profit (normalised)

1.3

2.1

6.6

12.0

19.0

Net profit (reported)

0.3

2.4

(19.7)

12.0

19.0

Average number of shares (m)

164.9

178.9

211.6

218.8

218.8

Average number of shares, diluted (m)

173.3

185.9

218.6

225.8

225.8

EPS normalised (€)

0.01

0.01

0.03

0.05

0.09

EPS normalised diluted (€)

0.00

0.01

0.03

0.05

0.08

EPS reported (€)

0.00

0.01

(0.09)

0.05

0.09

DPS (€)

0.00

0.00

0.00

0.00

0.02

Revenue growth

9.8%

21.1%

22.2%

21.1%

23.7%

Gross Margin

33.2%

29.8%

31.0%

31.1%

31.2%

Normalised EBITDA Margin

10.1%

8.6%

12.3%

14.7%

15.8%

Normalised Operating Margin

4.4%

3.5%

7.0%

9.9%

11.7%

Reported EBIT margin

4.5%

3.4%

-32.6%

9.9%

11.7%

BALANCE SHEET

Fixed Assets

155.6

195.3

189.4

222.4

218.6

Intangible Assets

10.9

10.8

6.8

6.6

6.4

Tangible Assets

144.4

181.3

151.4

184.6

181.1

Investments & other

0.3

3.2

31.2

31.2

31.2

Current Assets

72.5

79.8

72.2

86.2

121.4

Stocks

12.3

20.4

25.9

31.4

38.9

Debtors

9.8

13.2

12.1

13.2

16.3

Other current assets

2.8

4.2

3.9

4.6

5.5

Cash & cash equivalents

47.6

42.1

30.4

37.1

60.8

Current Liabilities

42.3

45.7

41.0

46.3

53.4

Creditors

9.5

16.7

14.2

16.9

20.5

Other current liabilities

22.2

16.4

14.0

16.7

20.2

Short term borrowings

10.6

12.7

12.7

12.7

12.7

Long Term Liabilities

49.2

56.5

66.5

71.5

71.5

Long term borrowings

49.2

56.5

66.5

71.5

71.5

Other long term liabilities

0.0

0.0

0.0

0.0

0.0

Shareholders' equity

136.6

172.9

154.2

190.9

215.2

Minority interests

37.2

35.5

35.5

35.5

35.5

Balance sheet total

228.1

275.1

261.7

308.7

340.1

CASH FLOW

Op Cash Flow before WC and tax

10.2

10.3

14.7

26.3

34.9

Working capital

8.3

(9.2)

(8.9)

(2.0)

(4.4)

Exceptional & other

(1.9)

(1.5)

3.5

4.0

4.5

Tax

0.1

0.1

(0.6)

(1.4)

(2.2)

Net interest

3.4

2.9

(3.0)

(3.5)

(4.0)

Net operating cash flow

20.1

2.6

5.6

23.3

28.8

Capex

(12.4)

(45.3)

(31.9)

(41.6)

(5.1)

Investments in financial assets/joint ventures

(1.1)

(3.8)

(28.0)

0.0

0.0

Equity financing

9.4

34.9

28.8

20.0

0.0

Dividends

0.0

0.0

0.0

0.0

0.0

Other

(3.9)

(3.3)

0.0

0.0

0.0

Net Cash Flow

12.1

(14.9)

(25.5)

1.7

23.7

Opening net debt/(cash), including lease liabilities

24.3

12.2

27.2

52.6

50.9

Closing net debt/(cash), including lease liabilities

12.2

27.2

52.6

50.9

27.2

Source: Accsys Technologies, Edison Investment Research

General disclaimer and copyright

This report has been commissioned by Accsys Technologies and prepared and issued by Edison, in consideration of a fee payable by Accsys Technologies. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2022 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by Accsys Technologies and prepared and issued by Edison, in consideration of a fee payable by Accsys Technologies. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2022 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Accsys Technologies

View All

Latest from the Industrials sector

View All Industrials content

Industrials

ACWA Power — Record results for FY23

Industrials

Dowlais Group — Motoring forward

Research: Consumer

Games Workshop Group — Encouraging trading in H123

Games Workshop’s (GAW’s) H123 trading update indicates an encouraging start to the year, with reported revenue and operating profit representing more than half of our full year estimate. With around three-quarters of revenue earned overseas, GAW is a beneficiary of sterling’s weakness, notably versus the US dollar, which alone, we estimate, contributed c 6% to GAW’s core revenue growth in H123. Although sterling has recently strengthened, at current exchange rates it continues to provide good support for the remainder of the year. We upgrade our FY23 and FY24 revenue estimates by c 2% due to favourable exchange rates, but maintain our prior profit estimates. Our discounted cash flow-based valuation of £100/share is unchanged ahead of publication of H123 results.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free